IDP-107

· Dow Pharmaceutical Sciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IDP-107, covering 2012-02-20 to 2012-07-02. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris [Phase 2]